| |
David M. Panchision, PhD
Investigator, Center for Neuroscience Research Assistant
Professor, Dept. of Pediatrics and Pharmacology George Washington University
School of Medicine Children's Research Institute Children's National
Medical Center 111 Michigan Avenue, N.W., Suite 5340 Washington, DC
20010-2970 202-476-2269 (Ph) 202-476-4988 (Fx) dpanchision@cnmcresearch.org NIH Biosketch
Training B.S., 1987 (Biology), College of William and
Mary Ph.D., 1994 (Pharmacology), Medical College of Virginia, Virginia
Commonwealth University Postdoctoral, 1994-2003, NINDS, National Institutes
of Health, Laboratory of Dr. Ron McKay
Laboratory Members Hui-ling
Chen, Ph.D. (Postdoctoral Fellow)
Research Interests Our interest is in the
self-organizing principles that govern the production of stem cells, the
generation of cellular diversity and the assembly of tissues. The field of stem
cell biology has emerged as a bridge between the traditional fields of cell
biology and developmental genetics. Stem cells have certain defining
characteristics, including the ability to self-renew extensively and the ability
to generate diverse daughter cell types. These cells can therefore be used as
tools to study developmentally relevant switches between alternative states,
including proliferation versus mitotic arrest, survival versus apoptosis, and
multiple fate choices.
Our laboratory uses a
defined culture model for assaying the properties and potential of neural stem
cells from many ages. These stem cells are easily manipulated and can be
efficiently directed to generate multiple cell types and higher order
structures. We have also developed vectors that drive the specific and efficient
expression of genes in precursor cells of the developing neural tube. These
vectors permit a comparative in vivo and invitro analysis of gene function in
these cells. Our comparison of results from in vitro and in vivo analysis
supports the idea that complex developmental processes can be reproduced and
analyzed in vitro using defined methods.
We are interested in how
switches in alternative states are coordinated in space and time to generate the
cell types and tissue shapes with which we are familiar. We are currently
focusing on BMP signaling on neural stem cells as a paradigm to address these
questions. These results may have general relevance to other developmentally
important signaling pathways and to stem cells from other tissues. Additionally,
we are interested in the role that these pathways may have in tissue turnover,
regeneration and dysregulation in disease states such as cancer.
A feed-forward mechanism controls dorsal neural precursor
production and fate. Bone morphogenetic proteins (BMPs) are secreted
ligands that have diverse and sometimes paradoxical effects during embryonic
development, including the nervous system. To determine the mechanisms
underlying BMP actions, we analyzed the expression of two BMP receptors, BMPR-IA
and BMPR-IB, in neural precursor cells in vitro and in vivo. Neural precursor
cells always express Bmpr-1a, but Bmpr-1b is not expressed until embryonic day 9
and is restricted to the dorsal neural tube surrounding the source of BMP
ligands. We then expressed active and inactive mutant forms of the receptors
under the control of pNERV and analyzed their effects in transgenic mice and
cultured CNS stem cells. BMPR-IA activation induces (and the ventralizing
actions of Sonic hedgehog repressed) expression of Bmpr-1b along with dorsal
identity genes in neural stem cells and promotes the proliferation of these
dorsalized cells. BMPR-IB activation limited cell numbers by causing mitotic
arrest. This results in apoptosis in early gestation embryos and terminal
differentiation in mid-gestation embryos. The linked and antagonistic actions of
these receptors can be dissociated using loss-of-function receptor mutants.
Furthermore, a single BMP ligand can drive this feedforward, self-limiting
process in cultured stem cells. Thus, BMP actions on stem cells are first
inducing (through BMPR-IA) and then terminating (through BMPR-IB). We speculate
that the accumulation of BMPR-IB relative to BMPR-IA in each exposed cell may
determine whether cells continue to proliferate or undergo mitotic arrest and
differentiate.
BMPs use divergent pathways to
generate alternative fates. Stem cells exhibit both age-dependent and
density-dependent differences in cell fate in response to BMPs. For example,
when fetal forebrain stem cells are grown at low density, BMP treatment results
in predominantly myofibroblast generation. At higher densities BMP treatment
leads to predominantly Schwann cell generation. While SMAD activation is
required for myofibroblast generation, it is not required for Schwann cell
generation. Conversely, STAT activation, which is required for instruction to
the Schwann cell fate, occurs only at high density in response to BMPs. The
serine-threonine kinase FRAP is required for the activation of STAT proteins in
response to BMPs. Thus, alternative fates are generated by distinct pathways
acting downstream of BMP receptor activation.
Stem Cell
Dysfunction in the Etiology of Cancer. Central Nervous System (CNS)
tumors are one of the most highly prevalent forms of cancer in the US and are
the leading cause of cancer deaths in children. Recent studies provide evidence
that cancers can be re-initiated by cells with properties similar to stem cells.
These cells comprise a small percentage of the tumor cell population but can
reconstitute the phenotypic heterogeneity of the original tumor. This suggests
that cancer is caused by stem cell dysfunction. We are investigating the
relationship between improper stem cell regulation in the brain and the
progression of cancer. This may lead to the development of more selective
therapies for the treatment of CNS tumors.
Recent Publications
Kim, J-H., Panchision,
D., Kittappa, R., and McKay, R. (2003) Generating CNS neurons from
embryonic, fetal and adult stem cells. In Methods Enzymol. Vol 365: 303-327 (PM
Wassarman and GM Keller, eds) Academic Press.
*Rajan, P.,
*Panchision, D.M., Newell, L., and McKay, R.D. (2003). BMP
signals alternate through a SMAD or FRAP-STAT pathway to regulate fate choice in
CNS stem cells. J. Cell Biology 161:911-921. *Equal contribution.
Panchision, D.M., and McKay, R.D. (2002). The control
of neural stem cells by morphogenic signals. Curr. Opin. Genet. Dev. 12:478-487.
Panchision, D.M., Pickel, J.M., Studer, L., Lee, S.H.,
Turner, P.A., Hazel, T.G., and McKay, R.D. (2001). Sequential actions of BMP
receptors control neural precursor production and fate. Genes & Development
15:2094-2110.
Panchision, D.M., Hazel, T.H., and McKay,
R.D. (1998). Plasticity and stem cells in the vertebrate nervous system. Curr.
Opin. Cell Biol. 10:727-733.
Panchision, D.M.,
Martin-DeLeon, P.A., Takeshima, T., Johnston, J.M., Shimoda, K., Tsoulfas, P.,
McKay, R.D., and Commissiong, J.W. (1998). An immortalized, type-1 astrocyte of
mesencephalic origin: source of a dopaminergic neurotrophic factor. J. Mol.
Neurosci 11:209-221.
|
|